Evolent Announces Third Quarter 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Evolent Health (EVH) Tops Q3 EPS by 23c; Offers FY23 Revenue Guidance
November 2, 2023 4:45 PM EDTEvolent Health (NYSE: EVH) reported Q3 EPS of $0.30, $0.23 better than the analyst estimate of $0.07. Revenue for the quarter came in at $511 million versus the consensus estimate of $509.21 million.
GUIDANCE:
Evolent Health sees FY2023 revenue of $1.95-1.97 billion, versus the consensus of... More
